2023
1) Yoshitomo Morinaga, Hiroshi Yamada, Yoshihiro Yoshida, Hitoshi Kawasuji, Yoshihiro Yamamoto. Analytical sensitivity of six lateral flow antigen test kits for variant strains of SARS-CoV-2. J Infect Chemother. 2023 Feb; 29(2): 131-135. doi:10.1016/j.jiac.2022.10.004.
2) Kawasuji H, Morinaga Y, Tani H, Saga Y, Yamada H, Yoshida Y, Takegoshi Y, Kaneda M, Murai Y, Kimoto K, Ueno A, Miyajima Y, Nagaoka K, Ono C, Matsuura Y, Niimi H, Yamamoto Y. Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5. Microbiol Spectr. 2023 Mar 22; 11(2): e0513122. doi: 10.1128/spectrum.05131-22.
3) Kentaro Nagaoka, Hitoshi Kawasuji, Yusuke Takegoshi, Yushi Murai, Makito Kaneda, Kou Kimoto, Hideki Tani, Hideki Niimi, Yoshitomo Morinaga, Kyo Noguchi, Yoshihiro Yamamoto. Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants. Viruses. 2023 May 31; 15(6): 1304. doi: 10.3390/v15061304.
4) Kawata S, Morimoto S, Kosai K, Kawamoto Y, Nakashima Y, Morinaga Y, Yanagihara K, Yoshida LM, Moriuchi H. The fecal carriage rate of extended-spectrum β-lactamase-producing or carbapenem-resistant Enterobacterales among Japanese infants in the community at the 4-month health examination in a rural city. Front Cell Infect Microbiol. 2023 Jun 14; 13:1168451. doi: 10.3389/fcimb.2023.1168451.
5) K Nagaoka, H Kawasuji, Y Takegoshi, Y Murai, M Kaneda, A Ueno, Y Miyajima, M Wakasugi, K Noguchi, S Morimoto,Y Morinaga, Y Yamamoto. Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19. Eur Radiol. 2023 Jul; 33(7): 4713-4722. doi: 10.1007/s00330-023-09427-0.
NEWS
2022
1) Kawamoto Y, Kaku N, Akamatsu N, Sakamoto K, Kosai K, Morinaga Y, Ohmagari N, Izumikawa K, Yamamoto Y, Mikamo H, Kaku M, Oishi K, Yanagihara K. The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan. Int J Antimicrob Agents. 2022 Jan; 59(1): 106480.
doi: 10.1016/ j.ijantimicag.2021.106480.
2) Nagaoka K, Kawasuji H, Murai Y, Kaneda M, Ueno A, Miyajima Y, Fukui Y, Morinaga Y, Yamamoto Y. Circulating type I interferon levels in the early phase of COVID-19 are associated with the development of respiratory failure. Front Immunol.2022 Feb 14; 13: 844304. doi: 10.3389/fimmu.2022.844304.
3) Kondo T, Sakamoto K, Morinaga Y, Miyata Y, Yanagihara K, Sakai H. Escherichia coli ST131 isolated from urologicalpatients can acquire plasmid-mediated extended spectrum β-lactamase from other bacteria with high frequency. Int j Urol.2022 Mar 14; 29(6): 587-594.
doi: 10.1111/iju.14845.
4) Ito Y, Takazono T, Obase Y, Fukahori S, Ashizawa N, Hirayama T, Tashiro M, Yamamoto K, Imamura Y, Hosogaya N,Fukushima C, Morinaga Y, Yanagihara K, Izumikawa K, Mukae H. Serum cytokines usefulness for understanding thepathology in allergic bronchopulmonary aspergillosis and chronic pulmonary aspergillosis. J Fungi (Basel). 2022 Apr 23;8(5): 436.
doi: 10.3390/jof8050436.
5) Ozawa T, Tani H, Anraku Y, Kita S, Igarashi E, Saga Y, Inasaki N, Kawasuji H, Yamada H, Sasaki SI, Somekawa M, Sasaki J, Hayakawa Y, Yamamoto Y, Morinaga Y, Kurosawa N, Isobe M, Fukuhara H, Maenaka K, Hashiguchi T, Kishi H, Kitajima I, Saito S, Niimi H. Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants. MAbs. 2022 May 11; 14(1): 2072455. doi: 10.1080/19420862.2022.2072455.
NEWS
ラジオ日経「呼吸器ウイルス感染症のこれから」
Morinaga Y / 2022 Jul 11
チューリップテレビ「富大が発表 3回目接種『オミクロン株にも効果』」にてコメントが放映されました Morinaga Y / 2022 Jul 11.
2021
1) Tani H, Kimura M, Tan L, Yoshida Y, Ozawa T, Kishi H, Fukushi S, Saijo M, Sano K, Suzuki T, Kawasuji H, Ueno A,Miyajima Y, Fukui Y, Sakamaki I, Yamamoto Y, Morinaga Y. Evaluation of SARS-CoV-2 neutralizing antibodies using avesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Virol J. 2021 Jan 12; 18(1): 16. doi:10.1186/s12985-021-01490-7.
2) Kuwatsuka S, Kuwatsuka Y, Tomimura S, Takenaka M, Terasaka Y, zumikawa K, Morinaga Y, Yanagihara K, Murota H. Impact of daily wearing of fabric gloves on the management of hand eczema: A pilot study in health-care workers. J Dermatol. 2021 May; 48(5): 645-50. doi: 10.1111/1346-8138.15848.
3) Taniguchi D, Watanabe H, Morinaga Y, Sasaki D, Matsuda J, Sato S, Kaku N, Miyazaki T, Matsumoto K, Tsuchiya T, Sakaeda T, Yanagihara K, Nagayasu T. Safety, efficacy, and analysis of key parameters after prophylactic administration of a sustained-release formulation of azithromycin in lung cancer surgery. Ann Palliat Med. 2021 May; 10(5): 5098-107. doi: 10.21037/apm-21-383.
4) Kaku N, Kodama H, Akamatsu N, Ota K, Kosai K, Morinaga Y, Narita Y, Matsumoto Y, Matsushita T, Mizuta Y, Izumikawa K, Mukae H, Yanagihara K. Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness. J Infect Chemother. 2021 Jun; 27(6): 820-5. doi: 10.1016/j.jiac.2021.01.010.
5) Yamada H, Taniguchi S, Shimojima M, Tan L, Kimura M, Morinaga Y, Fukuhara T, Matsuura Y, Komeno T, Furuta Y, Saijo M, Tani H. M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening. Viruses. 2021 Jun 3; 13(6): 1061. doi: 10.3390/v13061061.
NEWS
European Journal of Clinical Microbiology & Infectious Diseases誌に論文が掲載されることとなりました/Morinaga Y.2021.Feb.9
Journal of Infection and Chemotherapy誌に論文が掲載されることとなりました/Morinaga Y.2021.Jan.25
NHK富山放送局、ケーブルテレビ、北日本新聞、富山新聞「感染症医療人養成にむけた富山大学の教育への取り組み」コメント放映・掲載されました/Morinaga Y.2021,Nov.16
NHK富山放送局の番組で集団食中毒についてのコメントが放映されました/Morinaga Y.2021.Jun.19
Virology Journal誌に当大学感染症学講座と、富山県衛生研究所が中心となり、当大学免疫学、国立感染症研究所と共同で行った新型コロナウイルスに対する免疫力を示す中和抗体に関する論文が掲載されました/Morinaga Y.2021,Jan.12
2020
1) Tani H, Kimura M, Tan L, Yoshida Y, Ozawa T, Kishi H, Fukushi S, Saijo M, Sano K, Suzuki T, Kawasuji H, Ueno A,Miyajima Y, Fukui Y, Sakamaki I, Yamamoto Y, Morinaga Y. Evaluation of SARS-CoV-2 neutralizing antibodies using avesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Virol J. 2021 Jan 12; 18(1): 16. doi:10.1186/s12985-021-01490-7.
2) Kuwatsuka S, Kuwatsuka Y, Tomimura S, Takenaka M, Terasaka Y, zumikawa K, Morinaga Y, Yanagihara K, Murota H. Impact of daily wearing of fabric gloves on the management of hand eczema: A pilot study in health-care workers. J Dermatol. 2021 May; 48(5): 645-50. doi: 10.1111/1346-8138.15848.
3) Taniguchi D, Watanabe H, Morinaga Y, Sasaki D, Matsuda J, Sato S, Kaku N, Miyazaki T, Matsumoto K, Tsuchiya T, Sakaeda T, Yanagihara K, Nagayasu T. Safety, efficacy, and analysis of key parameters after prophylactic administration of a sustained-release formulation of azithromycin in lung cancer surgery. Ann Palliat Med. 2021 May; 10(5): 5098-107. doi: 10.21037/apm-21-383.
4) Kaku N, Kodama H, Akamatsu N, Ota K, Kosai K, Morinaga Y, Narita Y, Matsumoto Y, Matsushita T, Mizuta Y, Izumikawa K, Mukae H, Yanagihara K. Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness. J Infect Chemother. 2021 Jun; 27(6): 820-5. doi: 10.1016/j.jiac.2021.01.010.
5) Yamada H, Taniguchi S, Shimojima M, Tan L, Kimura M, Morinaga Y, Fukuhara T, Matsuura Y, Komeno T, Furuta Y, Saijo M, Tani H. M Segment-Based Minigenome System of Severe Fever with Thrombocytopenia Syndrome Virus as a Tool for Antiviral Drug Screening. Viruses. 2021 Jun 3; 13(6): 1061. doi: 10.3390/v13061061.
NEWS
ournal of Medical Microbiology誌に論文が掲載されました/Morinaga Y_2020,Nov.3
Infection and Chemotherapy誌に当大学感染症科と共同での論文が掲載されました/Morinaga Y,2020Aug.20
Interdisciplinary Neurosurgery誌に当大学脳神経外科と共同での論文が掲載されました/Morinaga Y,2020Jul.
教員4名が学長表彰を受けました/ Morinaga Y, Tani H, Yamada H, Kimura M, 2020,Apr.23
富山テレビ放送の番組「報道ライブBBT」でPCR検査についてのコメントが放映されました/Morinaga Y, 2020,Apr.21